Ginkgo Bioworks Holdings (MEX:DNA) Tariff Resilience Score: 8/10 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DNA Ginkgo Bioworks Holdings Inc MEX:DNA
54 GF Score
Price MXN170.00
GF Value MXN149.41
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Tariff Resilience Score?

Ginkgo Bioworks Holdings MEX:DNA 54 Tariff Resilience Score is 8 as of Aug. 02, 2026. GuruFocus rates MEX:DNA with a GF Score™ of 54/100 and a GF Value™ of MXN149.41 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,368 Biotechnology companies, Ginkgo Bioworks Holdings ranks better than 98.68% on this metric.

Ginkgo Bioworks Holdings has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Ginkgo Bioworks Holdings has Ginkgo Bioworks, focused on synthetic biology, has limited direct exposure to tariffs. Its operations are primarily domestic, and its innovative nature allows flexibility in sourcing and production.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Ginkgo Bioworks Holdings might have Highly Resilient.

Ginkgo Bioworks Holdings  (MEX:DNA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Ginkgo Bioworks Holdings Tariff Resilience Score Related Terms

MEX:DNA vs RZLT, EIKN, ARTV: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ginkgo Bioworks Holdings Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's Tariff Resilience Score falls into.


MEX:DNA
54GF Score
Ginkgo Bioworks Holdings Inc MEX:DNA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Ginkgo Bioworks Holdings (MEX:DNA) has a Tariff Resilience Score of 8 as of Aug. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Ginkgo Bioworks Holdings ranks #18 out of 1368 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Ginkgo Bioworks Holdings' Tariff Resilience Score too high?
Ginkgo Bioworks Holdings' current Tariff Resilience Score is 8. The Biotechnology industry median Tariff Resilience Score is 4.00. Ginkgo Bioworks Holdings' value of 8 is 100% above this industry median. Based on the distribution chart, Ginkgo Bioworks Holdings ranks #18 out of 1368 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Tariff Resilience Score compare to RZLT and EIKN?
According to the Biotechnology industry distribution chart, Ginkgo Bioworks Holdings ranks #18 out of 1368 companies for Tariff Resilience Score. This places Ginkgo Bioworks Holdings in the top 1% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Ginkgo Bioworks Holdings' value of 8 is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,368 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginkgo Bioworks Holdings's current Tariff Resilience Score of 8 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginkgo Bioworks Holdings's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ginkgo Bioworks Holdings (MEX:DNA) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN149.41, compared to a current price of MXN170.00 — trading 13.8% above its estimated fair value. The current Tariff Resilience Score is 8 and 100% above the Biotechnology industry median of 4.00. Ginkgo Bioworks Holdings' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (MEX:DNA), the current Tariff Resilience Score is 8 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ginkgo Bioworks Holdings (MEX:DNA) Overvalued in 2026?

Based on GuruFocus' analysis, Ginkgo Bioworks Holdings stock appears to be overvalued. The current stock price of MXN170.00 is trading 13.8% above its estimated GF Value™ of MXN149.41. GuruFocus considers Ginkgo Bioworks Holdings to be Modestly Undervalued.

Key valuation signals for MEX:DNA:

  • Tariff Resilience Score: 8
  • GF Value™: MXN149.41 vs. price of MXN170.00 (13.8% above fair value)
  • GF Score™: 54/100 with 5 warning signs
  • Industry Position: 100% above the Biotechnology median (#18 of 1368)

No single metric tells the full story. See the MEX:DNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USA
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
54GF Score

Get the complete analysis for MEX:DNA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price
MXN149.41
GF Value